The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with <i>FUS‐TFCP2</i> fusion transcript
Anne‐Cécile Brunac, Anne Laprie, Marie‐Pierre Castex, Camille Laurent, François Le Loarer, Marie Karanian, Sophie Le Guellec, Delphine Guillemot, Gaëlle Pierron, Anne Gomez‐Brouchet
Abstract
The authors declare that there is no conflict of interest. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
MedicineRhabdomyosarcomaFusion transcriptFusion geneCancer researchRadiation therapyComputational biologyBioinformaticsSarcomaInternal medicinePathologyGeneGeneticsBiologySarcoma Diagnosis and TreatmentLymphoma Diagnosis and TreatmentTumors and Oncological Cases